Skip to main content
. 2022 Jun 21;12:884782. doi: 10.3389/fonc.2022.884782

Figure 2.

Figure 2

Safety and efficacy of CD19hs CAR-T. (A) CRS following CD19m CAR-T and CD19hs CAR-T infusions. (B) CR rates after the 1st and 2nd infusions of CD19m CAR-T and CD19hs CAR-T, respectively.